Academic Neurology Unit, Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK.
Brain. 2011 Feb;134(Pt 2):506-17. doi: 10.1093/brain/awq345. Epub 2011 Jan 12.
Gene expression profiling has been used previously with spinal cord homogenates and laser capture microdissected motor neurons to determine the mechanisms involved in neurodegeneration in amyotrophic lateral sclerosis. However, while cellular and animal model work has focused on superoxide dismutase 1-related amyotrophic lateral sclerosis, the transcriptional profile of human mutant superoxide dismutase 1 motor neurons has remained undiscovered. The aim of this study was to apply gene expression profiling to laser captured motor neurons from human superoxide dismutase 1-related amyotrophic lateral sclerosis and neurologically normal control cases, in order to determine those pathways dysregulated in human superoxide dismutase 1-related neurodegeneration and to establish potential pathways suitable for therapeutic intervention. Identified targets were then validated in cultured cell models using lentiviral vectors to manipulate the expression of key genes. Microarray analysis identified 1170 differentially expressed genes in spinal cord motor neurons from superoxide dismutase 1-related amyotrophic lateral sclerosis, compared with controls. These genes encoded for proteins in multiple functional categories, including those involved in cell survival and cell death. Further analysis determined that multiple genes involved in the phosphatidylinositol-3 kinase signalling cascade were differentially expressed in motor neurons that survived the disease process. Functional experiments in cultured cells and primary motor neurons demonstrate that manipulating this pathway by reducing the expression of a single upstream target, the negative phosphatidylinositol-3 kinase regulator phosphatase and tensin homology, promotes a marked pro-survival effect. Therefore, these data indicate that proteins in the phosphatidylinositol-3 kinase pathway could represent a target for therapeutic manipulation in motor neuron degeneration.
基因表达谱分析以前曾被用于脊髓匀浆和激光捕获微切割运动神经元,以确定肌萎缩侧索硬化症中涉及的神经退行性变的机制。然而,虽然细胞和动物模型研究集中在超氧化物歧化酶 1 相关的肌萎缩侧索硬化症上,但人类突变超氧化物歧化酶 1 运动神经元的转录谱仍未被发现。本研究的目的是应用基因表达谱分析从人类超氧化物歧化酶 1 相关肌萎缩侧索硬化症和神经正常对照病例中激光捕获的运动神经元,以确定在人类超氧化物歧化酶 1 相关神经退行性变中失调的途径,并建立适合治疗干预的潜在途径。然后使用慢病毒载体在培养的细胞模型中验证鉴定出的靶标,以操纵关键基因的表达。微阵列分析鉴定出超氧化物歧化酶 1 相关肌萎缩侧索硬化症脊髓运动神经元中 1170 个差异表达的基因,与对照组相比。这些基因编码多种功能类别的蛋白质,包括参与细胞存活和细胞死亡的蛋白质。进一步的分析确定,在经历疾病过程后存活下来的运动神经元中,参与磷脂酰肌醇-3 激酶信号级联的多个基因表达存在差异。在培养的细胞和原代运动神经元中的功能实验表明,通过降低单个上游靶标,即负性磷脂酰肌醇-3 激酶调节剂磷酸酶和张力蛋白同源物的表达,操纵该途径可促进明显的促生存作用。因此,这些数据表明,磷脂酰肌醇-3 激酶途径中的蛋白质可能是运动神经元退化治疗干预的靶点。